Expert Consensus on the Use of the PRESERFLO™ MicroShunt Device in the Treatment of Glaucoma: A Modified Delphi Panel

INTRODUCTION: The implantation of the PRESERFLO™ MicroShunt (PMS) device has been shown to significantly lower increased intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG). However, guidelines on best practice for patient selection and pre-/peri-/postoperative care manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Khawaja, Anthony P., Stalmans, Ingeborg, Aptel, Florent, Barton, Keith, Beckers, Henny, Klink, Thomas, Marchini, Giorgio, Martínez de la Casa, Jose, Simonsen, Jan H., Töteberg-Harms, Marc, Vass, Clemens, Abegão Pinto, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437199/
https://www.ncbi.nlm.nih.gov/pubmed/35797005
http://dx.doi.org/10.1007/s40123-022-00529-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437199/
https://www.ncbi.nlm.nih.gov/pubmed/35797005
http://dx.doi.org/10.1007/s40123-022-00529-4

Ejemplares similares